NCT03502915View on ClinicalTrials.gov

Nitrous Oxide for External Cephalic Version

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

February 14, 2019

Study Completion Date

February 14, 2019

Conditions
External Cephalic Version
Interventions
DRUG

Nitrous Oxide

50% nitrous oxide/50% oxygen via Nitronox delivery device

OTHER

Placebo

100% oxygen via Nitronox delivery device

Trial Locations (1)

27514

University of North Carolina, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT03502915 - Nitrous Oxide for External Cephalic Version | Biotech Hunter | Biotech Hunter